Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma.
Sato Y, Nakano K, Fukuda N, Wang X, Urasaki T, Ohmoto A, Yunokawa M, Ono M, Tomomatsu J, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Takahashi S.
Sato Y, et al. Among authors: ae k.
Anticancer Res. 2021 Jan;41(1):527-532. doi: 10.21873/anticanres.14804.
Anticancer Res. 2021.
PMID: 33419852